Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Titlesort ascending Journal
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data Journal for ImmunoTherapy of Cancer
Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series Journal of Immunotherapy
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research
Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open
Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety
External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International
Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics
Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology
Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology
ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts Bioinformatics
Enhancing the analytic utility of clinical trial data to inform health disparities research Contemporary Clinical Trials Communications
Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies Urologic Oncology: Seminars and Original Investigations
Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial Clinical Genitourinary Cancer
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients International Journal of Clinical Oncology

Pages